These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11380489)

  • 21. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
    Petersons CJ; Mangelsdorf BL; Thompson CH; Burt MG
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
    Rodríguez-Arnao J; Perry L; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
    al-Shoumer KA; Gray R; Anyaoku V; Hughes C; Beshyah S; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Masked type 1 diabetes mellitus (T1DM) unveiled by glucocorticoid replacement: a case of simultaneous development of T1DM and hypophysitis in an elderly woman.
    Aikawa E; Horie I; Naganobu K; Nozaki A; Kamada A; Abiru N; Kawakami A
    Endocr J; 2020 Nov; 67(11):1163-1168. PubMed ID: 32669510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.
    Tanaka Y; Atsumi Y; Asahina T; Hosokawa K; Matsuoka K; Kinoshita J; Onuma T; Kawamori R
    Diabetes Care; 1998 Jul; 21(7):1133-7. PubMed ID: 9653608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance.
    Melchionda N; Forlani G; Marchesini G; Baraldi L; Natale S
    Int J Obes Relat Metab Disord; 2002 Jan; 26(1):90-6. PubMed ID: 11791152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or levothyroxine.
    Nishioka H; Haraoka J
    J Endocrinol Invest; 2005 Jun; 28(6):528-33. PubMed ID: 16117194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche.
    Ibáñez L; Castell C; Tresserras R; Potau N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):395-401. PubMed ID: 10583304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Tormey W; Smith D; Thompson CJ; McKenna MJ; Agha A
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
    Abs R; Bengtsson BA; Hernberg-Stâhl E; Monson JP; Tauber JP; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
    Pfeifer M; Kanc K; Verhovec R; Kocijancic A
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism.
    Ragnarsson O; Nyström HF; Johannsson G
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):246-52. PubMed ID: 21767286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.
    Gómez-Pérez FJ; Aguilar-Salinas CA; López-Alvarenga JC; Perez-Jauregui J; Guillen-Pineda LE; Rull JA
    Diabetes Care; 1998 Nov; 21(11):1886-8. PubMed ID: 9802737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.
    Bülow B; Erfurth EM
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):45-55. PubMed ID: 10341855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fasting or post-challenge blood glucose values for detection of glucose intolerance in screening for metabolic syndrome?].
    Jermendy G; Hidvégi T; Hetyési K; Bíró L
    Orv Hetil; 2002 Sep; 143(39):2247-52. PubMed ID: 12418378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.
    Lancet; 1999 Aug; 354(9179):617-21. PubMed ID: 10466661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.